New Delhi: India could join the 26 countries to approve Russia’s Sputnik V COVID-19 vaccine in the next few weeks, RIA news agency cited India’s ambassador to Moscow as saying on Monday.
The trials of the vaccine have been started in small batches by India’s Dr. Reddy’s Laboratories Ltd. The lab had earlier stated that Sputnik V meets the primary safety requirements for phase-2 clinical trials in India.
The mid-stage trial data have been submitted to the drug regulator.
The Lancet medical journal stated that the Russian vaccine is more effective than the Chinese ones, and it has 91.6 per cent success rate.
The Sputnik V can be stored in a fridge unlike Pfizer and Moderna’s vaccines.
In September 2020, Dr. Reddy’s and Russian Direct Investment Fund (RDIF) entered into a partnership to conduct its clinical trials.
Also Read: First Trial: Oxford COVID-19 Vaccine To Be Tested On Children
Bhadrak: Police busted a sex racket operating from a hotel in Odisha's Bhadrak district late… Read More
New Delhi: Delhi Metro Rail Corporation (DMRC) claimed to have scaled the highest point till… Read More
Bhubaneswar: The Odisha Vigilance sleuths on Sunday apprehended Assistant Agriculture Officer lock Technology Manager and… Read More
New Delhi: In a revealing account, Elon Musk has shed light on the dramatic circumstances… Read More
Kolkata: With emotions running high well before Indian and Pakistan clash for Champions Trophy in… Read More
Bhubaneswar: The India Meteorological Department (IMD) has issued nowcast warning for six districts of Odisha… Read More
This website uses cookies.
